Roles of alendronate and simvastatin in prevention of bone loss in ovariectomized rats

Seung Jun Ryu, Jin Sae Yoo, Aeyong Eom, Sangbaek Koh, Jae Won Choi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The aim of this study was to investigate the effect of simvastatin for preventing and treating osteoporosis compared to alendronate, the standard treatment of choice in osteoporosis, in a rat model. Weight change, bone mineral density, and the bone volume/total volume ratio obtained through histological analysis were used to compare the effects of simvastatin to those of alendronate. In simvastatin-treated animals, bone mineral density increased by 4 to 8% compared to a negative control group, while alendronate-treated animals showed an increase of 13%. The bone volume/total volume ratio in the simvastatin group ranged from 0. 53 to 0. 76, while alendronate-treated animals showed a range from 0. 44 to 0. 51. We also found that simvastatins are more effective for preventing bone loss when administered in early osteoporosis rather than in advanced osteoporosis. The results of the present study indicate that simvastatin is more effective for maintaining bone volume, while alendronate is more effective for maintaining bone mineral density, in a rat model. Therefore, simvastatin may prevent bone loss in early menopausal women.

Original languageEnglish
Pages (from-to)114-119
Number of pages6
JournalToxicology and Environmental Health Sciences
Volume3
Issue number2
DOIs
Publication statusPublished - 2011 Dec 1

Fingerprint

Alendronate
Simvastatin
Rats
Bone
Bone and Bones
Osteoporosis
Bone Density
Minerals
Animals
Weights and Measures
Control Groups

All Science Journal Classification (ASJC) codes

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Ryu, Seung Jun ; Yoo, Jin Sae ; Eom, Aeyong ; Koh, Sangbaek ; Choi, Jae Won. / Roles of alendronate and simvastatin in prevention of bone loss in ovariectomized rats. In: Toxicology and Environmental Health Sciences. 2011 ; Vol. 3, No. 2. pp. 114-119.
@article{69bd8f00a52e4d619b81f3e9ae31aa99,
title = "Roles of alendronate and simvastatin in prevention of bone loss in ovariectomized rats",
abstract = "The aim of this study was to investigate the effect of simvastatin for preventing and treating osteoporosis compared to alendronate, the standard treatment of choice in osteoporosis, in a rat model. Weight change, bone mineral density, and the bone volume/total volume ratio obtained through histological analysis were used to compare the effects of simvastatin to those of alendronate. In simvastatin-treated animals, bone mineral density increased by 4 to 8{\%} compared to a negative control group, while alendronate-treated animals showed an increase of 13{\%}. The bone volume/total volume ratio in the simvastatin group ranged from 0. 53 to 0. 76, while alendronate-treated animals showed a range from 0. 44 to 0. 51. We also found that simvastatins are more effective for preventing bone loss when administered in early osteoporosis rather than in advanced osteoporosis. The results of the present study indicate that simvastatin is more effective for maintaining bone volume, while alendronate is more effective for maintaining bone mineral density, in a rat model. Therefore, simvastatin may prevent bone loss in early menopausal women.",
author = "Ryu, {Seung Jun} and Yoo, {Jin Sae} and Aeyong Eom and Sangbaek Koh and Choi, {Jae Won}",
year = "2011",
month = "12",
day = "1",
doi = "10.1007/s13530-011-0086-1",
language = "English",
volume = "3",
pages = "114--119",
journal = "Toxicology and Environmental Health Sciences",
issn = "2005-9752",
publisher = "Korean Society of Environmental Risk Assessment and Health Science",
number = "2",

}

Roles of alendronate and simvastatin in prevention of bone loss in ovariectomized rats. / Ryu, Seung Jun; Yoo, Jin Sae; Eom, Aeyong; Koh, Sangbaek; Choi, Jae Won.

In: Toxicology and Environmental Health Sciences, Vol. 3, No. 2, 01.12.2011, p. 114-119.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Roles of alendronate and simvastatin in prevention of bone loss in ovariectomized rats

AU - Ryu, Seung Jun

AU - Yoo, Jin Sae

AU - Eom, Aeyong

AU - Koh, Sangbaek

AU - Choi, Jae Won

PY - 2011/12/1

Y1 - 2011/12/1

N2 - The aim of this study was to investigate the effect of simvastatin for preventing and treating osteoporosis compared to alendronate, the standard treatment of choice in osteoporosis, in a rat model. Weight change, bone mineral density, and the bone volume/total volume ratio obtained through histological analysis were used to compare the effects of simvastatin to those of alendronate. In simvastatin-treated animals, bone mineral density increased by 4 to 8% compared to a negative control group, while alendronate-treated animals showed an increase of 13%. The bone volume/total volume ratio in the simvastatin group ranged from 0. 53 to 0. 76, while alendronate-treated animals showed a range from 0. 44 to 0. 51. We also found that simvastatins are more effective for preventing bone loss when administered in early osteoporosis rather than in advanced osteoporosis. The results of the present study indicate that simvastatin is more effective for maintaining bone volume, while alendronate is more effective for maintaining bone mineral density, in a rat model. Therefore, simvastatin may prevent bone loss in early menopausal women.

AB - The aim of this study was to investigate the effect of simvastatin for preventing and treating osteoporosis compared to alendronate, the standard treatment of choice in osteoporosis, in a rat model. Weight change, bone mineral density, and the bone volume/total volume ratio obtained through histological analysis were used to compare the effects of simvastatin to those of alendronate. In simvastatin-treated animals, bone mineral density increased by 4 to 8% compared to a negative control group, while alendronate-treated animals showed an increase of 13%. The bone volume/total volume ratio in the simvastatin group ranged from 0. 53 to 0. 76, while alendronate-treated animals showed a range from 0. 44 to 0. 51. We also found that simvastatins are more effective for preventing bone loss when administered in early osteoporosis rather than in advanced osteoporosis. The results of the present study indicate that simvastatin is more effective for maintaining bone volume, while alendronate is more effective for maintaining bone mineral density, in a rat model. Therefore, simvastatin may prevent bone loss in early menopausal women.

UR - http://www.scopus.com/inward/record.url?scp=84873260165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873260165&partnerID=8YFLogxK

U2 - 10.1007/s13530-011-0086-1

DO - 10.1007/s13530-011-0086-1

M3 - Article

AN - SCOPUS:84873260165

VL - 3

SP - 114

EP - 119

JO - Toxicology and Environmental Health Sciences

JF - Toxicology and Environmental Health Sciences

SN - 2005-9752

IS - 2

ER -